Addressing Global Cancer Care Inequities Using Implementation Science and Community-Engaged Research Approaches

Abstract

Advances in cancer prevention efforts, screening and early detection, and treatments have contributed to steady reductions in cancer mortality for individuals in high-income countries in recent years. Yet, these benefits have not yet been realised for many populations across the globe, particularly for those residing in low- and middle-income countries, and in other medically underserved communities. Addressing cancer disparities will require targeted efforts to equitably improve cancer care delivery across the care continuum; from detection, through treatment, and to survivorship. This feature article describes how implementation science and community-engaged approaches can address cancer inequities by improving the delivery, uptake, and effective expansion of evidence-based cancer care in real-world resource-limited settings.

Apoptosis-inducing anti-proliferative and quantitative phytochemical profiling with in silico study of antioxidant-rich Leea aequata L. leaves

“…Due to their wide range of clinical applications and excellent therapeutic efficacy, researchers strive to exploit secondary metabolites as a novel source in drug discovery [ [1] , [2] , [3] , [4] , [5] ]. Extensive research has been performed to identify novel agents from natural sources such as plants, fruits, vegetables, extracts, and biomolecules to develop effective and natural therapeutic approaches for preventing and treating various cancers because cancer led to nearly 10 million deaths worldwide in 2020, or nearly one in six deaths, and its incidence is increasing daily [ 6 ]. According to cancer statistics for 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States [ 7 ].…”